BusinessIndustry Leaders Urge Patient Capital for India's Biotech Innovation
At the CII Pharma and Life Sciences Summit, industry leaders emphasized the need for patient capital, larger investments, policy predictability, and a risk capital pool to boost novel drug innovation in India's biotech start-ups. They highlighted that sustained financial support is crucial for advancing new drug development and strengthening the biotech sector.
The Hindu - Business Line·




